Friday, August 9, 2024

CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol could be risk factors for dementia. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Aug 9, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Friday, August 9, 2024

0:00 9:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 9 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on August 9, 2024.

Can I download this The Gist Healthcare Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!